Why is Emmessar Biotech & Nutrition Ltd ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-44.75%
EBIT Growth (5y)
-204.56%
EBIT to Interest (avg)
-0.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.90
Sales to Capital Employed (avg)
0.29
Tax Ratio
46.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
-71.58%
ROE (avg)
17.56%
Valuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
44
Price to Book Value
1.50
EV to EBIT
-3.18
EV to EBITDA
-3.42
EV to Capital Employed
4.86
EV to Sales
4.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-147.00%
ROE (Latest)
4.80%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
Technical Movement
1What is working for the Company
PAT(9M)
Higher at Rs 0.28 Cr
-3What is not working for the Company
ROCE(HY)
Lowest at 7.14%
DEBTORS TURNOVER RATIO(HY)
Lowest at 18.00 times
Loading Valuation Snapshot...
Here's what is working for Emmessar Biotech
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.28 Cr
than preceding 12 month period ended Jun 2026 of Rs 0.23 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Emmessar Biotech
Debtors Turnover Ratio- Half Yearly
Lowest at 18.00 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio